A randomized, phase 2 trial of docetaxel with or without PX-866, an irreversible oral phosphatidylinositol 3-kinase inhibitor, in patients with relapsed or metastatic head and neck squamous cell cancer
Titel:
A randomized, phase 2 trial of docetaxel with or without PX-866, an irreversible oral phosphatidylinositol 3-kinase inhibitor, in patients with relapsed or metastatic head and neck squamous cell cancer
Auteur:
Jimeno, Antonio Bauman, Julie E. Weissman, Charles Adkins, Douglas Schnadig, Ian Beauregard, Patrice Bowles, Daniel W. Spira, Alexander Levy, Benjamin Seetharamu, Nagashree Hausman, Diana Walker, Luke Rudin, Charles M. Shirai, Keisuke